1. Home
  2. ENSC vs IFBD Comparison

ENSC vs IFBD Comparison

Compare ENSC & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • IFBD
  • Stock Information
  • Founded
  • ENSC 2003
  • IFBD 2001
  • Country
  • ENSC United States
  • IFBD China
  • Employees
  • ENSC N/A
  • IFBD N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • IFBD Computer Software: Prepackaged Software
  • Sector
  • ENSC Health Care
  • IFBD Technology
  • Exchange
  • ENSC Nasdaq
  • IFBD Nasdaq
  • Market Cap
  • ENSC 2.9M
  • IFBD 2.6M
  • IPO Year
  • ENSC N/A
  • IFBD 2021
  • Fundamental
  • Price
  • ENSC $3.29
  • IFBD $1.03
  • Analyst Decision
  • ENSC
  • IFBD
  • Analyst Count
  • ENSC 0
  • IFBD 0
  • Target Price
  • ENSC N/A
  • IFBD N/A
  • AVG Volume (30 Days)
  • ENSC 4.9M
  • IFBD 24.6K
  • Earning Date
  • ENSC 05-12-2025
  • IFBD 01-01-0001
  • Dividend Yield
  • ENSC N/A
  • IFBD N/A
  • EPS Growth
  • ENSC N/A
  • IFBD N/A
  • EPS
  • ENSC N/A
  • IFBD N/A
  • Revenue
  • ENSC $5,210,031.00
  • IFBD $1,437,848.00
  • Revenue This Year
  • ENSC N/A
  • IFBD N/A
  • Revenue Next Year
  • ENSC N/A
  • IFBD N/A
  • P/E Ratio
  • ENSC N/A
  • IFBD N/A
  • Revenue Growth
  • ENSC 133.58
  • IFBD 413.52
  • 52 Week Low
  • ENSC $1.62
  • IFBD $1.11
  • 52 Week High
  • ENSC $14.67
  • IFBD $5.60
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 55.92
  • IFBD 35.21
  • Support Level
  • ENSC $3.02
  • IFBD $0.89
  • Resistance Level
  • ENSC $4.85
  • IFBD $1.07
  • Average True Range (ATR)
  • ENSC 0.40
  • IFBD 0.17
  • MACD
  • ENSC 0.27
  • IFBD -0.02
  • Stochastic Oscillator
  • ENSC 51.70
  • IFBD 22.58

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service, provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process including pre-sales and sales activities and post-sales customer support. It also offers AI-powered cloud-based sales force management software including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performances of agents.

Share on Social Networks: